NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

 
MANGALAM Technical Analysis
3
As on 18th Apr 2024 MANGALAM SHARE Price closed @ 99.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 105.05 & Sell for SHORT-TERM with Stoploss of 108.56 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MANGALAMSHARE Price

Open 101.00 Change Price %
High 102.35 1 Day -0.80 -0.80
Low 98.55 1 Week -2.25 -2.22
Close 99.15 1 Month -1.30 -1.29
Volume 31399 1 Year -14.35 -12.64
52 Week High 162.55 | 52 Week Low 96.75
 
NSE INDIA Most Active Stocks
IDEA 13.20 1.93%
YESBANK 23.90 -0.21%
TATASTEEL 160.05 0.00%
POWERGRID 280.10 2.13%
DHANI 51.45 7.19%
NHPC 89.50 -1.86%
EXIDEIND 449.65 -2.21%
GTLINFRA 1.75 2.94%
INDUSTOWER 344.40 3.58%
PNB 129.55 0.78%
 
NSE INDIA Top Gainers Stocks
KMSUGAR 36.05 19.97%
JUSTDIAL 1009.35 13.27%
ORICONENT 43.40 12.87%
SOLARA 473.80 11.97%
TPLPLASTEH 84.25 11.29%
ELIN 164.05 10.58%
ELIN 164.05 10.58%
DSSL 1248.65 10.31%
INDOTECH 1575.40 10.00%
ESSARSHPNG 31.35 10.00%
 
NSE INDIA Top Losers Stocks
STLTECH 129.95 -8.65%
SADBHAV 29.55 -8.51%
COFFEEDAY 64.70 -7.70%
BHAGERIA 172.70 -6.88%
GODHA 0.70 -6.67%
HINDMOTORS 20.50 -6.61%
TIRUPATIFL 17.90 -6.04%
GAYAHWS 0.85 -5.56%
IGL 437.30 -5.49%
IGL 437.30 -5.49%
 
 
MANGALAM
Daily Charts
MANGALAM
Intraday Charts
Whats New @
Bazaartrend
MANGALAM
Free Analysis
 
MANGALAM Important Levels Intraday
RESISTANCE106.47
RESISTANCE104.12
RESISTANCE102.67
RESISTANCE101.22
SUPPORT97.08
SUPPORT95.63
SUPPORT94.18
SUPPORT91.83
 
MANGALAM Target April 2024
4th UP Target185.79
3rd UP Target165.43
2nd UP Target152.84
1st UP Target140.26
1st DOWN Target104.34
2nd DOWN Target91.76
3rd DOWN Target79.17
4th DOWN Target58.81
 
MANGALAM Weekly Target
4th UP Target115.90
3rd UP Target111.67
2nd UP Target109.05
1st UP Target106.43
1st DOWN Target98.97
2nd DOWN Target96.35
3rd DOWN Target93.73
4th DOWN Target89.50
 
MANGALAM Target2024
4th UP Target243.06
3rd UP Target196.59
2nd UP Target167.86
1st UP Target139.13
1st DOWN Target57.17
2nd DOWN Target28.44
3rd DOWN Target-0.29
4th DOWN Target-46.76
 
 
MANGALAM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 27.03
10 Day Avg Volume Traded -35.67 % Less then 10 Day Average Volume
 
MANGALAM Other Details
Segment EQ
Market Capital 2224694016.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
MANGALAM Address
MANGALAM
 
MANGALAM Latest News
 
Your Comments and Response on Mangalam Drugs And Organics Limited
 
MANGALAM Business Profile
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India. Address: Rupam Building, Mumbai, India, 400001
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service